A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)
Clinical trial NCT04439071 · TERMINATED
Trial details
- NCT number
- NCT04439071
- Sponsor
- PTC Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-09
- Primary completion
- 2022-07-20
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.